ID: ALA538992

Max Phase: Preclinical

Molecular Formula: C9H11ClFNO

Molecular Weight: 167.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NC/C(=C/F)c1cccc(O)c1

Standard InChI:  InChI=1S/C9H10FNO.ClH/c10-5-8(6-11)7-2-1-3-9(12)4-7;/h1-5,12H,6,11H2;1H/b8-5-;

Standard InChI Key:  NFDLUEBGRNABPE-HGKIGUAWSA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 167.18Molecular Weight (Monoisotopic): 167.0746AlogP: 1.66#Rotatable Bonds: 2
Polar Surface Area: 46.25Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.52CX Basic pKa: 8.85CX LogP: 0.68CX LogD: -0.47
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.70Np Likeness Score: 0.37

References

1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M..  (1985)  Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.,  28  (2): [PMID:3968682] [10.1021/jm00380a007]

Source